Nucleo Longevity
ENIT

Quercetin

quercetin

A flavonoid with senolytic action, often combined with dasatinib.

TypeSupplement / dietary

The grade answers: What does the human evidence support for: Senolytic action?

Quercetin — 2D chemical structure
Structure · PubChem

Grade

C

Limited

The grade rates evidence quality — it is not advice to take or buy.

Class
Senolytics
Primary use
Senolytic action
Evidence strength
low
Last reviewed
2025-09-01

Bottom line

A genuinely interesting idea — clearing 'zombie' senescent cells — but the human evidence is early, tiny, and mostly tied to the prescription drug dasatinib, not quercetin alone.

What the evidence says

Quercetin is the best-known 'natural' half of the senolytic pairing dasatinib + quercetin (D+Q), the combination that produced the first human senolytic pilot data. The concept is compelling: selectively push senescent cells into apoptosis to reduce their inflammatory output. But the human trials so far are very small, use the drug combination rather than quercetin by itself, and target specific diseases (e.g. pulmonary fibrosis, diabetic kidney disease) rather than healthy aging. On its own, quercetin's bioavailability is poor. Grade C reflects a promising but immature field.

Key studies

  1. [1]

    First-in-human senolytic trial (dasatinib + quercetin) in pulmonary fibrosis · pilot trial

    Early feasibility signal on physical function — very small, open-label.

    Open on PubMed ↗
  2. [2]

    Senolytics reduce senescent cell burden in humans (D+Q) · pilot trial

    Showed a fall in senescent-cell markers — proof of concept, not proof of benefit.

    Open on PubMed ↗
  3. [3]

    Quercetin bioavailability and pharmacokinetics (review) · review

    Absorption is low and variable, complicating dosing claims.

    Open on PubMed ↗
See all studies on PubMed ↗

Scoped PubMed search, not a curated bibliography: the individual PMIDs for this entry have not yet been verified one by one. For that reason it is not used to support a high grade and is awaiting review.

Mechanism

Acts as a senolytic by interfering with pro-survival pathways that senescent cells depend on, tipping them toward apoptosis. Also has general antioxidant and anti-inflammatory activity as a dietary flavonoid — which is a different, weaker claim than true senolysis.

Safety

Well tolerated as a normal dietary flavonoid (onions, apples, capers, tea). The senolytic *protocols* are a different matter: D+Q involves a prescription chemotherapy agent (dasatinib) and belongs strictly in a clinical/trial setting, not in self-experimentation.

Dosage context

As a supplement, quercetin has low oral bioavailability, and doses/cycles vary widely. In senolytic research it is dosed intermittently ('hit-and-run') alongside dasatinib — a regimen that should not be replicated outside a trial.

Examples of application

  • Eaten in the diet (onions, capers, apples) as a flavonoid.
  • As a supplement, sometimes taken with vitamin C for absorption.
  • The senolytic D+Q protocol belongs in trials, not at home.

From the field

The senolytic field is promising but young, and quercetin is often marketed as if the D+Q trial results were its own. They aren't. We keep it at C and flag that the interesting protocols involve a prescription drug.

Related molecules

SpermidineB

Follow this entry

We'll tell you if the grade for Quercetin changes.

One review a week: new evidence, grade changes and what was updated. No hype, no promotions disguised as news.

How we assign grades → Method